Your dog was diagnosed with Anal Sac Apocrine Gland Adenocarcinoma. Accounts for ~2% of cutaneous/subcutaneous tumours and ~17% of perianal tumours. Paraneoplastic hypercalcaemia in 25-50% at diagnosis. High metastatic rate to sublumbar lymph nodes (50-80% at diagnosis). Compare 4 treatment options for dogs including Sacculectomy (Surgery Alone), Surgery + Adjuvant Chemotherapy, Surgery + Radiation Therapy — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Anal Sac Apocrine Gland Adenocarcinoma
Canine Oncology Treatment Guide
Anal Sac Apocrine Gland Adenocarcinoma
Epithelial
About This Cancer
Anal sac apocrine gland adenocarcinoma arises from the specialised scent glands within the anal sacs, two small pouches located on either side of the anus. These glands normally produce a pungent, oily secretion used for territorial marking. The cancer is notable for two features: it frequently spreads early to the sublumbar (internal pelvic) lymph nodes — these are already involved in 50–80% of cases at diagnosis — and it commonly produces a protein called parathyroid hormone-related protein (PTHrP) that causes dangerously elevated blood calcium levels (hypercalcaemia) in 25–50% of affected dogs. This paraneoplastic hypercalcaemia can cause kidney damage, weakness, and loss of appetite, and is sometimes the first clinical sign that prompts investigation. Spaniel breeds appear to be at higher risk. Treatment typically involves surgical removal of the affected anal sac, often combined with chemotherapy.
Modified staging for canine ASAGAC
No universally agreed TNM staging. Commonly stratified by tumour size, lymph node status, and distant metastasis.
Prognostic Factors(3)
Minimum Workup(8 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.